A less traumatic way of delivering surfactant, a lung lubricant that premature babies need to help them breathe, could reduce the incidence of respiratory problems they'll have later, Medical College of Georgia physicians say.The problem is that while surfactant keeps the tiny air sacs inside the lungs from sticking together when they inflate and deflate while breathing, the delivery method causes trauma to the respiratory system and can lead to chronic lung disease, says Dr.
(more...)

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) to market its epoprostenol, the first generic version of GlaxoSmithKline's Flolan® for Injection. Teva's approval is for the 0.5 mg base/vial and 1.5 mg base/vial strengths as well as the sterile diluent.
(more...)

Adults with the common rhinosinusitis infection should not beprescribed antibiotics, even if the symptoms are reported as lastinglonger than 7-10 days, according to an Article released on March 14,2008 in The Lancet. The third most common reason for a patient to consult a doctor is anupper respiratory tract infection. Rhinosinusitis, or infection of thenose and sinuses, is identified in its acute form in approximately onethird of these cases.
(more...)

Researchers at the University of Sheffield have developed innovative technology which illuminates a person's lungs and helps clinicians identify if they are functioning correctly. The new technology could result in earlier diagnosis of emphysema and smoking related damage, as well as other lung conditions and diseases.Lung diseases are of growing concern to the health of the nation, with people suffering from conditions as mild as asthma or as severe as lung cancer.
(more...)

Pneumonia, irregular heart beats, and obstructed blood flow to the heart are the the three main factors precipitating two out of three patients being admitted to hospital in the US for heart failure, said researchers.The investigation is published in the 28th April issue of the Archives of Internal Medicine and is the work of researchers and clinicians based at University of California Los Angeles (UCLA), and other research centres and clinics throughout the US.
(more...)

Caliper Life Sciences, Inc. (Nasdaq: CALP) announced that the Texas A&M Health Science Center Research Foundation (HSCRF) is using the IVIS Spectrum imaging system to speed the development of more effective therapeutic treatments for tuberculosis. Research efforts and the purchase of the IVIS system are funded through a grant to the Texas A&M Health Science Center from the Bill & Melinda Gates Foundation.
(more...)

New findings show a link between micronutrient supplementation and reduced risk of recurrence during tuberculosis chemotherapy, according to a study published in the June 1 issue of The Journal of Infectious Diseases, now available online.
(more...)

Aeolus Pharmaceuticals, Inc. (OTC Bulletin Board: AOLS) reported that researchers from National Jewish Research and Medical Center and the University of Colorado have completed a series of studies demonstrating that AEOL 10150 provides statistically significant protection of the lungs and skin in the 2-chloroethyl-ethylsulfide (CEES; half mustard) model of mustard gas exposure in rats.
(more...)

When suffering through a sinus infection, many people ask for an antibiotic to speed their recovery. However, a recent review of clinical trials found that while antibiotics can provide minor improvements in uncomplicated sinusitis cases, most patients recover without the drugs within two weeks.
(more...)

Tuesday, May 6, 2008, is World Asthma Day and the National Asthma Council Australia is urging the two million plus Australians with asthma to prepare, or update, their asthma action plans. According to National Asthma Council Australia chairman, Professor John Wilson, asthma prevalence in this country is relatively high but we can minimise its impact through greater awareness and understanding.
(more...)